compound 4g [PMID: 2680437]   Click here for help

GtoPdb Ligand ID: 9198

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 4g is a GSK-3β inhibitor with anti-inflammatory activity [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 78.22
Molecular weight 327.05
XLogP 2.46
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=c1oc2c(n1Cc1nnn(c1)c1ccccc1Cl)nccc2
Isomeric SMILES O=c1oc2c(n1Cc1nnn(c1)c1ccccc1Cl)nccc2
InChI InChI=1S/C15H10ClN5O2/c16-11-4-1-2-5-12(11)21-9-10(18-19-21)8-20-14-13(23-15(20)22)6-3-7-17-14/h1-7,9H,8H2
InChI Key DVUFHXDFLFFOFE-UHFFFAOYSA-N
Bioactivity Comments
Compound 4g shows 76% in vivo anti-inflammatory activity (5h post-carrageenan administration) and was further found to inhibit production of the pro-inflammatory mediators, NO, TNFα, IL-1β, and IL-6 substantially more than in comparison with the anti-inflammatory drug indomethacin, and the GSK-3 inhibitor SB 216763 [1]
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
glycogen synthase kinase 3 beta Hs Inhibitor Inhibition 6.7 pIC50 - 1
pIC50 6.7 (IC50 1.9x10-7 M) [1]
Description: Evaluated in a Kinase-Glo assay.